alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2009019EN.01003402.xml

| 24.1.2009 | EN | Official Journal of the European Union | C 19/34 |
| --- | --- | --- | --- |

24.1.2009

EN

Official Journal of the European Union

C 19/34

---

Action brought on 21 November 2008 — Psytech International v OHIM — Institute for Personality & Ability Testing (16PF)

(Case T-507/08)

(2009/C 19/64)

Language in which the application was lodged: English

Parties

Applicant: Psytech International Ltd (Pulloxhill, United Kingdom) (represented by: N. Phillips, Solicitor and N. Saunders, Barrister)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal: Institute for Personality & Ability Testing, Inc. (Champaign, United States)

Other party to the proceedings before the Board of Appeal:

Form of order sought

| — | Annul the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 23 July 2008 in case R 1012/2007-2 and remit the application for a declaration of invalidity to the OHIM to allow it to proceed, and |
| --- | --- |

—

Annul the decision of the Second Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 23 July 2008 in case R 1012/2007-2 and remit the application for a declaration of invalidity to the OHIM to allow it to proceed, and

| — | Order OHIM to pay the costs. |
| --- | --- |

—

Order OHIM to pay the costs.

Pleas in law and main arguments

Registered Community trade mark subject of the application for a declaration of invalidity: The word mark ‘16PF’ for goods and services in classes 9, 16, 35, 41 and 42 — Community trade mark registration No 1 892 652

Registered Community trade mark subject of the application for a declaration of invalidity:

Proprietor of the Community trade mark: The other party to the proceedings before the Board of Appeal

Proprietor of the Community trade mark:

Party requesting the declaration of invalidity of the Community trade mark: The applicant

Party requesting the declaration of invalidity of the Community trade mark:

Decision of the Cancellation Division: Rejection of the request for a declaration of invalidity

Decision of the Cancellation Division:

Decision of the Board of Appeal: Dismissal of the appeal

Decision of the Board of Appeal:

Pleas in law: Infringement of Articles 7(1)(b), 7(1)(c), 7(1)(d) and 51(1)(b) of Council Regulation 40/94 as the Board of Appeal: (i) should have found on the evidence before it that the registered Community trade mark subject of the application for a declaration of invalidity was devoid of any distinctive character; (ii) failed to apply the correct legal test and failed to properly evaluate the evidence before it; and (iii) should have found on the evidence before it that the application for the registered Community trade mark subject of the application for a declaration of invalidity was made in bad faith.

Pleas in law:

---
Exhibit 10.12

FIRST AMENDMENT  TO  EMPLOYMENT AGREEMENT

This First Amendment to Employment Agreement dated and effective August 22, 2007 (this "Amendment"), amends
that certain Employment Agreement dated as of April 3, 2007 (the "Original Agreement") by and between United Online, Inc., a Delaware
corporation (the "Company"), with principal corporate offices at 21301 Burbank Boulevard, Woodland Hills, California 91367, and Mark R. Goldston, whose
address is 21301 Burbank Boulevard, Woodland Hills, California 91367 ("Employee"). Capitalized terms used herein and not otherwise defined herein have
the respective meanings set forth in the Original Agreement.

RECITALS

A.    Company
and Employee desire for Employee to serve, in addition to the capacities described in the Original Agreement, as Chief Executive Officer and Chairman of
Classmates Media Corporation, a Delaware corporation and/or such other entity as is formed to be the "IPO entity" described below ("Classmates"); and

B.    Company
and Employee desire to amend the Original Agreement as provided herein.

NOW,
THEREFORE, in consideration of the mutual promises set forth herein, the parties hereto hereby agree as follows:

1.     Section 2
of the Original Agreement is hereby amended and restated in its entirety by the following:



2.     Section 3.8
is hereby added to the Original Agreement as follows:



---





3.     A
new sentence is added to the end of the first paragraph of Section 4.3 of the Original Agreement, as follows:



4.     The
following is added to the end of Section 8.7 of the Original Agreement:



5.     Except
as expressly modified by this Amendment, the Original Agreement shall remain and continue in full force and effect.

(Signature Page Follows)

2

---



IN
WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.

| |  | UNITED ONLINE, INC.                 
| |  | ------------------------------------
| |  |                                     
| |  | By:                                 
| |  |                                     
| |  |                                     
| |  |                                     
| |  |                                     
| |  | By:                                 
| |  |                                     
| |  |                                     
| |  |                                     
| |  |                                     
| |  | /s/ Mark R. GoldstonMark R. Goldston

3

---



QuickLinks
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          30,338
<SECURITIES>                                         0
<RECEIVABLES>                                  590,994
<ALLOWANCES>                                    16,713
<INVENTORY>                                    719,625
<CURRENT-ASSETS>                             1,407,795
<PP&E>                                       3,764,145
<DEPRECIATION>                                 903,718
<TOTAL-ASSETS>                               5,254,252
<CURRENT-LIABILITIES>                        1,053,846
<BONDS>                                      1,259,270
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             1
<OTHER-SE>                                   1,846,439
<TOTAL-LIABILITY-AND-EQUITY>                 5,254,252
<SALES>                                     10,911,721
<TOTAL-REVENUES>                            10,980,641
<CGS>                                       10,340,219
<TOTAL-COSTS>                               10,582,715
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                13,826
<INTEREST-EXPENSE>                              99,926
<INCOME-PRETAX>                                296,777
<INCOME-TAX>                                   102,787
<INCOME-CONTINUING>                            193,990
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   193,990
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
[Federal Register Volume 89, Number 18 (Friday, January 26, 2024)]
[Notices]
[Page 5249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01522]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Human Genome Research Institute 
Initial Review Group; Genome Research Study Section.
    Date: March 7, 2024.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge, Drive Bethesda, MD 20817.
    Contact Person: Lori Bonnycastle, Ph.D., Scientific Review 
Officer, 50 South Drive, National Human Genome Research Institute, 
National Institute of Health, Building 50, Room 5314, Bethesda, MD 
20892, 301-594-9206, <a href="/cdn-cgi/l/email-protection#abc7c9c4c5c5d2c8caebc6cac2c785c5c2c385ccc4dd"><span class="__cf_email__" data-cfemail="88e4eae7e6e6f1ebe9c8e5e9e1e4a6e6e1e0a6efe7fe">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

    Dated: January 22, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01522 Filed 1-25-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1716 Introduced in Senate (IS)]

104th CONGRESS
  2d Session
                                S. 1716

 To amend the Public Health Service Act to reauthorize the adolescent 
 family life program, provide for abstinence education, and for other 
                               purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 29, 1996

 Mr. Specter (for himself, Mr. Santorum, Mr. Jeffords, Mr. Lugar, Mr. 
 Inouye, Mr. Leahy, Mr. Simpson, Mr. Hatfield, Mr. Coats, Mr. Stevens, 
    Mr. Pryor, Mr. Bond, Mr. Conrad, and Mr. DeWine) introduced the 
 following bill; which was read twice and referred to the Committee on 
                       Labor and Human Resources

_______________________________________________________________________

                                 A BILL

 
 To amend the Public Health Service Act to reauthorize the adolescent 
 family life program, provide for abstinence education, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Adolescent Family Life and 
Abstinence Education Act of 1996''.

SEC. 2. DEFINITIONS.

    Section 2002(a) of the Public Health Service Act (42 U.S.C. 300z-1) 
is amended in subparagraph (4)(G) by inserting ``and abstinence'' after 
``adoption''.

SEC. 3. GEOGRAPHIC DIVERSITY.

    (a) Section 2005 of the Public Health Service Act (42 U.S.C. 300z-
4) is amended by adding after subsection (a) the following:
    ``(b) In approving applications for grants for demonstration 
projects for services under this title, the Secretary shall, to the 
maximum extent practicable, ensure adequate representation of both 
urban and rural areas.''.
    (b) Section 2005 is amended by redesignating subsections (b) and 
(c) as subsections (c) and (d), respectively.

SEC. 4. SIMPLIFIED APPLICATION PROCESS.

    Section 2006 of the Public Health Service Act (42 U.S.C. 300z-5) is 
amended by adding the following:
    ``(g) The Secretary shall develop and implement a simplified and 
expedited application process for applicants seeking less than $15,000 
of funds available under this Act for a demonstration project.''

SEC. 5. AUTHORIZATION OF APPROPRIATIONS.

    Section 2010(a) of the Public Health Service Act is amended to read 
as follows:
    ``(a) For the purpose of carrying out this title (42 U.S.C. 300z et 
seq.), there are authorized to be appropriated $75,000,000 for each of 
the fiscal years 1996 through 2000.''.
                                 <all>
```
<PAGE>
                                                                  EXHIBIT 99.1

[LOGO]

                                       
                        ANNUAL STATEMENT AS TO COMPLIANCE


The undersigned certifies that she is an Assistant Vice President of 
BankAmerica Housing Services, a Division of Bank of America, FSB, (the 
"Servicer") and that, as such, she is duly authorized to execute and deliver 
this certificate on behalf of the Servicer pursuant to Section 4.20 of the 
Pooling and Servicing Agreement (the "Agreement") dated as of July 1, 1997, 
between Bank of America National Trust and Savings Association, Contract 
Seller, BankAmerica Housing Services, a Division of Bank of America, FSB, as 
Contract Seller and Services, and First National Bank, of Chicago, as 
Trustee of the Trust 1997-1, (all capitalized terms used herein without 
definition having the respective meanings specified in the Agreement) and 
further certifies that:

       1.  I have reviewed the activities during the preceding calendar year 
           and performance under this agreement has been made under such 
           officer's supervision under Section 4.20 of the Agreement; and

       2.  To the best of my knowledge, based on such review, the Servicer 
           has fulfilled all its obligations under this Agreement throughout 
           such year.

IN WITNESS WHEREOF, I have affixed hereunto my signature this 31st day of 
March, 1998.



                                      BANKAMERICA HOUSING SERVICES,
                                      a Division of Bank of America, FSB



                                      By  /s/ Mary Churley
                                          -----------------------------------
                                          Mary Churley
                                          Assistant Vice President and Manager
                                          Investor Servicing
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pane lunani m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l ar g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T E US E B I O L AG UN AS GA R C I A; E L I AZ ARGO NZ AL E Z AL ON Z O, P et i t i o n ers, v. E R I C H . H O L D E R , Jr ., A tto rn e yG e n e r a l, R e s p o n d e n t. N o. 05- 73895 A ge nc yN os . A 096- 057- 918

A 096- 057- 919 ME MOR AN DU M *

O n P e t i t i on f

orR e vi e w of

an O r de rof

the B o ar do f I m m ig r a tio n A p p e a ls S ubm i tt e d S e pt e m be r13, 2010 ** B e f o r e : S I L V E R M A N , C A L L A H A N , an dN .R . S M I T H , C ir c u it Ju d g e s . E usebi o L agun as G ar ci a andE l i az arG on za l ezA l on zo, hu sband andw i fe and na t i ve s and c i t i z e ns of M e xi c o, pe t i t i on pr o s e f orr e vi e w of

the B oar d of Im m i grat i on A pp ea l s’ (“ B IA ”) order denyi ng thei r m ot i on t o reopen rem ov al 

# FI LED SEP 23 2010 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALS05- 73895 2 proceedi ng s. O ur j uri sdi ct i on i s gov erned b y 8 U . S . C . § 1 25 2. W e deny i n p art an dd i s m i s s i n p artth e p e t i t i o n f o rr e v i e w. In thei r openi ng bri ef

, pet i t i on er s f

ai lt o add re ss , and there fore have w ai ved anyc ha l l e nge t o, the B I A ’ s June 3, 2005, de c i s i on de ny i ng the i rm ot i on t o r e ope n. Se e M a r t i n ez - Se rra n o v . I

NS , 94 F . 3d 1256, 1259- 60 ( 9th C i r . 1996) ( i s s ue s not spec i fi ca l l y r ai se d andar gu ed i n a party’ s openi ng bri ef ar e w ai ved). W e l a c k j ur i s di c t i on t o r e vi e w the B I A ’ s unde r l y i ng or de rdi s m i s s i ng p e titio n e r s ’ d ir e c t ap p e a l f r o m th e im m ig r a tio n ju d g e ’s d e c is io n b e c au s e th is p e titio n f o rr e v ie w is n o t tim e lya s to th a t o r d e r . Se e Si n gh v . I NS , 315 F . 3d 1186, 1 1 8 8 ( 9 th C ir . 2 0 0 3 ) . P E T IT IO N F O R R E V IE W D E N IE D i n p art; D IS M IS S E D i n p art.
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1591 Introduced in Senate (IS)]

104th CONGRESS
  2d Session
                                S. 1591

 To prohibit campaign expenditures for services of lobbyists, and for 
                            other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 6, 1996

  Mr. McCain introduced the following bill; which was read twice and 
         referred to the Committee on Rules and Administration

_______________________________________________________________________

                                 A BILL

 
 To prohibit campaign expenditures for services of lobbyists, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. AMENDMENT OF FECA.

    (a) In General.--Section 315 of the Federal Election Campaign Act 
of 1971 (2 U.S.C. 441a) is amended by adding at the end the following 
new subsection:
    ``(i) Notwithstanding any other provision of this Act, a candidate 
and the candidate's authorized committees shall not make disbursements 
for any services rendered by, any individual if such individual, was 
required to register as a lobbyist under the Lobbying Disclosure Act of 
1995 (2 U.S.C. 1601 et seq.).''.
    (b) Reporting.--Section 304(b) of the Federal Election Campaign Act 
of 1971 (2 U.S.C. 434(b)) is amended--
            (1) in paragraph (7), by striking ``and'' after the 
        semicolon;
            (2) in paragraph (8), by striking the period at the end and 
        inserting ``; and''; and
            (3) by adding at the end the following new paragraph:
            ``(9) for an authorized committee, an identification, 
        including the name and address, of any lobbyist (as that term 
        is defined in section 3 of the Lobbying Disclosure Act of 1995 
        (2 U.S.C. 1602)) who provided services to the authorized 
        committee, regardless of whether disbursements were made for 
        such services.''.

SEC. 2. AMENDMENT OF LOBBYING DISCLOSURE ACT OF 1995.

    Section 5(b) of the Lobbying Disclosure Act of 1995 (2 U.S.C. 
1604(b)) is amended--
            (1) in paragraph (3), by striking ``and'' after the 
        semicolon;
            (2) in paragraph (4), by striking the period at the end and 
        inserting ``; and''; and
            (3) by adding at the end the following new paragraph:
            ``(5) the amount and date of each contribution by the 
        registrant to a candidate, or an authorized committee (as that 
        term is defined in section 301 of the Federal Election Campaign 
        Act of 1971 (2 U.S.C. 431)) of a candidate, for the office of 
        Senator or Representative in, or Delegate or Resident 
        Commissioner to, the Congress.''.
                                 <all>
```
##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 8-K
 CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 Date
of Report (Date of the earliest event reported): March 10, 2009
 Valeant Pharmaceuticals International
  Delaware
    
    1-11397
    
    33-0628076(State or other jurisdiction of 
incorporation or organization)
    
    (Commission File Number)
    
    (I.R.S Employer
Identification No.)
 One Enterprise
Aliso Viejo, California 92656
 (949) 461-6000
  o
 o
 o
 o




---



TABLE OF CONTENTS  Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersSIGNATURES    Table of Contents  Item 5.02
    
    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
  Biographical and Other Information Regarding Dr. Chaudhuri
  Employment Arrangements with Dr. Chaudhuri
        2




---



##### Table of Contents



3




---



##### Table of Contents



SIGNATURES
  VALEANT PHARMACEUTICALS INTERNATIONALDate: March 19, 2009
    By:
    /s/ Steve T. MinSteve T. MinExecutive Vice President, General Counsel 4
##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 WASHINGTON, D.C. 20549
 FORM 8-K
 CURRENT REPORT
 Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported): February 20, 2008
 Valeant Pharmaceuticals International
  Delaware
(State or other jurisdiction of 
incorporation or organization)
    
    1-11397
(Commission File Number)
    
    33-0628076
(IRS Employer
Identification No.)
 One Enterprise 
Aliso Viejo, California
(Address of principal executive offices)
    
    92656
(Zip Code)
 (949) 461-6000
 N/A
   o
    
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 o
    
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 o
    
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 o
    
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




---



TABLE OF CONTENTS  Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01 Financial Statements and ExhibitsSIGNATURESEXHIBIT 3.1    Table of Contents  
 Item 5.03
    
    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
   
 Item 9.01
    
    Financial Statements and Exhibits.
  ExhibitNumber
    
    Exhibit Description3.1
    
    Amended and Restated Bylaws
 2.




---



##### Table of Contents



SIGNATURES
  Valeant Pharmaceuticals InternationalDate:  February 25, 2008
    By:
    /s/ Eileen C. PruetteEileen C. PruetteExecutive Vice President, General Counsel 3.




---



##### Table of Contents



Exhibit No.
    
    Description3.1
    
    Amended and Restated Bylaws
<PAGE>

EXHIBIT 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of EvergreenBancorp, Inc. (the
"Company") on Form 10-Q for the period ending September 30, 2003 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Gerald O. Hatler, Chief Executive Officer, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

     (1)  The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

/s/ Gerald O. Hatler

Gerald O. Hatler
Chief Executive Officer
November 12, 2003